Dr. Reddy's Laboratories Limited (RDY)
USD 14.55
(0.48%)
USD 14.55
(0.48%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 | 63.55 Billion INR | 30.58% |
| 2023 | 48.67 Billion INR | -4.35% |
| 2022 | 50.88 Billion INR | 12.05% |
| 2021 | 45.41 Billion INR | 29.5% |
| 2020 | 35.06 Billion INR | 4.43% |
| 2019 | 33.57 Billion INR | 15.44% |
| 2018 | 29.08 Billion INR | 1.96% |
| 2017 | 28.52 Billion INR | 11.54% |
| 2016 | 25.57 Billion INR | 0.19% |
| 2015 | 25.52 Billion INR | 6.41% |
| 2014 | 23.99 Billion INR | -88.89% |
| 2013 | 215.99 Billion INR | 1016.14% |
| 2012 | 19.35 Billion INR | 20.51% |
| 2011 | 16.05 Billion INR | 20.1% |
| 2010 | 13.37 Billion INR | 1.1% |
| 2009 | 13.22 Billion INR | 18.8% |
| 2008 | 11.13 Billion INR | 47.19% |
| 2007 | 7.56 Billion INR | 9.42% |
| 2006 | 6.91 Billion INR | 97.52% |
| 2005 | 3.49 Billion INR | 15.19% |
| 2004 | 3.03 Billion INR | 9.55% |
| 2003 | 2.77 Billion INR | 26.53% |
| 2002 | 2.19 Billion INR | 14.61% |
| 2001 | 1.91 Billion INR | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 52.39 Billion INR | 7.66% |
| 2024 Q3 | 60.79 Billion INR | 7.43% |
| 2024 FY | 63.55 Billion INR | 30.58% |
| 2024 Q4 | 63.55 Billion INR | 4.53% |
| 2024 Q2 | 56.59 Billion INR | 8.0% |
| 2023 Q3 | 49.32 Billion INR | 0.58% |
| 2023 Q1 | 51.81 Billion INR | 1.82% |
| 2023 FY | 48.67 Billion INR | -4.35% |
| 2023 Q4 | 48.67 Billion INR | -1.33% |
| 2023 Q2 | 49.04 Billion INR | -5.34% |
| 2022 Q1 | 50.77 Billion INR | 11.8% |
| 2022 FY | 50.88 Billion INR | 12.05% |
| 2022 Q2 | 49.7 Billion INR | -2.11% |
| 2022 Q4 | 50.88 Billion INR | 2.43% |
| 2022 Q3 | 49.67 Billion INR | -0.05% |
| 2021 Q2 | 41.13 Billion INR | 5.07% |
| 2021 FY | 45.41 Billion INR | 29.5% |
| 2021 Q1 | 39.14 Billion INR | 11.64% |
| 2021 Q4 | 45.41 Billion INR | 2.49% |
| 2021 Q3 | 44.3 Billion INR | 7.72% |
| 2020 Q1 | 35.13 Billion INR | 4.64% |
| 2020 FY | 35.06 Billion INR | 4.43% |
| 2020 Q4 | 35.06 Billion INR | -7.1% |
| 2020 Q3 | 37.74 Billion INR | 7.74% |
| 2020 Q2 | 35.03 Billion INR | -0.3% |
| 2019 Q3 | 33.91 Billion INR | 4.37% |
| 2019 FY | 33.57 Billion INR | 15.44% |
| 2019 Q1 | 31.49 Billion INR | 8.28% |
| 2019 Q2 | 32.49 Billion INR | 3.15% |
| 2019 Q4 | 33.57 Billion INR | -0.98% |
| 2018 Q3 | 26.82 Billion INR | -0.64% |
| 2018 FY | 29.08 Billion INR | 1.96% |
| 2018 Q1 | 28.09 Billion INR | -1.52% |
| 2018 Q2 | 26.99 Billion INR | -3.9% |
| 2018 Q4 | 29.08 Billion INR | 8.44% |
| 2017 FY | 28.52 Billion INR | 11.54% |
| 2017 Q4 | 28.52 Billion INR | -5.07% |
| 2017 Q3 | 30.05 Billion INR | 5.39% |
| 2017 Q2 | 28.51 Billion INR | 2.13% |
| 2017 Q1 | 27.92 Billion INR | 9.16% |
| 2016 Q4 | 25.57 Billion INR | -4.16% |
| 2016 FY | 25.57 Billion INR | 0.19% |
| 2016 Q2 | 27.14 Billion INR | 3.82% |
| 2016 Q3 | 26.68 Billion INR | -1.69% |
| 2016 Q1 | 26.14 Billion INR | 2.43% |
| 2015 Q3 | 29.03 Billion INR | 3.25% |
| 2015 Q2 | 28.12 Billion INR | 11.07% |
| 2015 Q4 | 25.52 Billion INR | -12.08% |
| 2015 Q1 | 25.31 Billion INR | 5.53% |
| 2015 FY | 25.52 Billion INR | 6.41% |
| 2014 FY | 23.99 Billion INR | -88.89% |
| 2014 Q1 | 22.53 Billion INR | -89.57% |
| 2014 Q2 | 23.87 Billion INR | 5.94% |
| 2014 Q3 | 24.15 Billion INR | 1.16% |
| 2014 Q4 | 23.99 Billion INR | -0.65% |
| 2013 Q2 | 21.88 Billion INR | 6.34% |
| 2013 FY | 215.99 Billion INR | 1016.14% |
| 2013 Q4 | 215.99 Billion INR | 832.26% |
| 2013 Q3 | 23.16 Billion INR | 5.87% |
| 2013 Q1 | 20.58 Billion INR | 6.35% |
| 2012 Q3 | 19.58 Billion INR | 5.35% |
| 2012 Q1 | 17.4 Billion INR | 8.36% |
| 2012 FY | 19.35 Billion INR | 20.51% |
| 2012 Q4 | 19.35 Billion INR | -1.19% |
| 2012 Q2 | 18.59 Billion INR | 6.84% |
| 2011 Q2 | 14.72 Billion INR | 1.92% |
| 2011 FY | 16.05 Billion INR | 20.1% |
| 2011 Q1 | 14.45 Billion INR | 8.08% |
| 2011 Q4 | 16.05 Billion INR | 5.35% |
| 2011 Q3 | 15.24 Billion INR | 3.5% |
| 2010 Q4 | 13.37 Billion INR | 3.59% |
| 2010 Q1 | 13.93 Billion INR | 5.35% |
| 2010 Q2 | 13.13 Billion INR | -5.72% |
| 2010 Q3 | 12.9 Billion INR | -1.74% |
| 2010 FY | 13.37 Billion INR | 1.1% |
| 2009 Q1 | 13.04 Billion INR | 17.16% |
| 2009 Q2 | 15.37 Billion INR | 17.9% |
| 2009 FY | 13.22 Billion INR | 18.8% |
| 2009 Q4 | 13.22 Billion INR | -12.74% |
| 2009 Q3 | 15.15 Billion INR | -1.43% |
| 2008 Q3 | 10.33 Billion INR | 7.64% |
| 2008 Q2 | 9.6 Billion INR | 13.74% |
| 2008 Q1 | 8.44 Billion INR | 11.61% |
| 2008 FY | 11.13 Billion INR | 47.19% |
| 2008 Q4 | 11.13 Billion INR | 7.72% |
| 2007 Q2 | 9.86 Billion INR | 12.08% |
| 2007 Q3 | 8.56 Billion INR | -13.15% |
| 2007 Q4 | 7.56 Billion INR | -11.72% |
| 2007 FY | 7.56 Billion INR | 9.42% |
| 2007 Q1 | 8.8 Billion INR | 27.32% |
| 2006 Q1 | 3.66 Billion INR | 4.87% |
| 2006 Q3 | 4.38 Billion INR | 8.46% |
| 2006 Q2 | 4.03 Billion INR | 10.06% |
| 2006 Q4 | 6.91 Billion INR | 57.78% |
| 2006 FY | 6.91 Billion INR | 97.52% |
| 2005 Q1 | 3.3 Billion INR | 8.79% |
| 2005 FY | 3.49 Billion INR | 15.19% |
| 2005 Q2 | 3.76 Billion INR | 13.82% |
| 2005 Q3 | 3.38 Billion INR | -10.02% |
| 2005 Q4 | 3.49 Billion INR | 3.38% |
| 2004 Q3 | 3.13 Billion INR | 0.16% |
| 2004 Q4 | 3.03 Billion INR | -3.11% |
| 2004 Q2 | 3.13 Billion INR | 8.14% |
| 2004 FY | 3.03 Billion INR | 9.55% |
| 2004 Q1 | 2.89 Billion INR | 4.39% |
| 2003 FY | 2.77 Billion INR | 26.53% |
| 2003 Q2 | 2.58 Billion INR | 1.77% |
| 2003 Q1 | 2.54 Billion INR | 16.04% |
| 2003 Q4 | 2.77 Billion INR | 2.74% |
| 2003 Q3 | 2.69 Billion INR | 4.28% |
| 2002 Q1 | 2.45 Billion INR | 0.0% |
| 2002 FY | 2.19 Billion INR | 14.61% |
| 2002 Q2 | 2.52 Billion INR | 2.81% |
| 2002 Q3 | 2.63 Billion INR | 4.34% |
| 2002 Q4 | 2.19 Billion INR | -16.81% |
| 2001 FY | 1.91 Billion INR | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Amneal Pharmaceuticals, Inc. | 581.38 Million USD | -10831.157% |
| Bausch Health Companies Inc. | 1.54 Billion USD | -4016.062% |
| Catalent, Inc. | 574 Million USD | -10971.777% |
| Emergent BioSolutions Inc. | 328.9 Million USD | -19222.59% |
| Elanco Animal Health Incorporated | 1.73 Billion USD | -3562.939% |
| Perrigo Company plc | 1.14 Billion USD | -5470.339% |
| Teva Pharmaceutical Industries Limited | 4.02 Billion USD | -1480.502% |
| Zoetis Inc. | 2.56 Billion USD | -2378.627% |